Company
Solstice Oncology, Inc.
Solstice Oncology, Inc. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Pembrolizumab | Phase 2 | Colon Cancer |
Latest
No recent events.
Follow Solstice Oncology, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.